[JEV News, August 5, 2011] In the August 3, 2011 online issue of Wall Street Journal, Pfizer Inc. was reportedly looking for a possibility of selling a new version of its best-selling cholesterol-lowering drug, Lipitor, for buying over the counter without prescription. The patent for Liptor will be expired in November 2011. The move by…
Recently, Pfizer was reportedly granted by the European Union to produce chewable form of Lipitor, a cholesterol-lowering drug. The chewable Lipitor is for children who are 10 years old and over and have high levels of LDLs and triglycerides, supposedly an inherited disease or familial hypercholesterolemia. [1] In 2002, Pfizer won approval of using Lipitor…
